Morgan Sturgis

Rush University, Rush University Medical Center

Papers

2

Total Citations

21

H-Index

2

About

Dr. Morgan Sturgis is a leading urologic oncologist whose research centers on optimizing surgical outcomes for upper tract urothelial cancer (UTUC). Her work has fundamentally advanced the field of minimally invasive radical nephroureterectomy (RNU), the gold-standard treatment for non-metastatic UTUC. In her landmark 2023 study, which has garnered 15 citations, Dr. Sturgis provided a critical five-year update on techniques and outcomes, demonstrating that minimally invasive approaches can achieve oncologic efficacy comparable to open surgery while reducing patient morbidity. She further solidified this evidence in a 2024 analysis of a large national database, comparing open versus minimally invasive RNU across a broad population. With 6 citations in its first year, this work offers real-world, generalizable insights that guide surgical decision-making. Dr. Sturgis’s research has been instrumental in shifting clinical practice toward less invasive treatments, directly improving recovery and quality of life for patients with UTUC. Her contributions continue to shape the standard of care in urologic oncology.

Research Focus

Key Achievements

2
H-Index
2
Papers
21
Total Citations
11
Avg Citations/Paper
🏆 Most Cited Paper
Minimally Invasive Radical Nephroureterectomy: 5-Year Update of Techniques and Outcomes
15 citations · 2023
📈 Most Prolific Year: 2023 (1 Papers)
🤝 Key Collaborators: 24
🏛 Institutions: Rush University, Rush University Medical Center

Top Papers

  1. 1
  2. 2

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 14 days ago